Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the page's version metadata rather than substantive content changes.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates an update to the page version and metadata.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's software revision tag was updated from v3.6.0 to v3.6.2, indicating a deployment or patch to the site's underlying platform rather than a change to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedNew reader guidance sections and a recruitment-status note were added to the study page, along with a minor formatting adjustment to the Intervention/Treatment label.SummaryDifference0.5%

- Check61 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5. This reflects a routine update to the site or page rendering without changes to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now includes a new revision tag, v3.5.4, replacing the previous v3.5.3, indicating a site update. This change does not modify the study details or related content.SummaryDifference0.1%

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.